Viela Bio’s (NYSE:VIE) quiet period is set to expire on Tuesday, November 12th. Viela Bio had issued 7,900,000 shares in its IPO on October 3rd. The total size of the offering was $150,100,000 based on an initial share price of $19.00. During the company’s quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
Several equities analysts recently commented on VIE shares. Morgan Stanley started coverage on shares of Viela Bio in a report on Monday, October 28th. They set an “overweight” rating and a $25.00 price target on the stock. Goldman Sachs Group started coverage on shares of Viela Bio in a report on Monday, October 28th. They set a “buy” rating and a $32.00 price target on the stock. Cowen started coverage on shares of Viela Bio in a report on Monday, October 28th. They set an “outperform” rating on the stock. Finally, Guggenheim initiated coverage on shares of Viela Bio in a report on Monday, October 28th. They set a “buy” rating and a $44.00 price target on the stock.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.